
Rochester, Minn. — Contrary to recent evidence, intravenous immunoglobulin (IVIg) may not be as effective as previously thought for treating various skin diseases, according to a retrospective review reported by the departments of dermatology at the Mayo Clinic, Rochester, Minn.